From UK market
Glaxo shares are biggest FTSE faller after MHRA medical experts say Avandia risks outweigh benefits
GlaxoSmithKline was the biggest faller in the FTSE 100 today after British medical experts demanded that Avandia, its controversial diabetes pill, be withdrawn from sale in the UK.
Glaxo closed down 19.5p at £12.49.
Other Avandia related stories over the past 24 hours:
The Telegraph - GSK shares hit by diabetes drug warning
Pharmacy News - Avandia cover up denial
Irish Independent - 5,000 diabetes patients told to keep taking 'risky' drug
Economic Times - Glaxo's Avandia should be pulled from market: BMJ
Daily Mail - GSK vows to stick by controversial diabetes drug
GSK - GlaxoSmithKline Right of Reply Statement About Controversial BBC Programme, Panorama.
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING